Walleye Capital’s Idexx Laboratories IDXX Stock Holding History

Walleye Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$95.5K	Sell	170 -13,261	-99%	-$8.5M	﹤0.01%	3692
2025 Q4	$9.09M	Buy	13,431 +13,152	+4,714%	+$8.96M	0.03%	728
2025 Q3	$178K	Buy	279 +48	+21%	+$29.1K	﹤0.01%	3390
2025 Q2	$124K	Buy	231 +118	+104%	+$56.4K	﹤0.01%	3667
2025 Q1	$47.5K	Sell	113 -68	-38%	-$29.5K	﹤0.01%	3864
2024 Q4	$74.8K	Sell	181 -30,689	-99%	-$13.5M	﹤0.01%	4242
2024 Q3	$15.6M	Buy	30,870 +9,016	+41%	+$4.38M	0.03%	449
2024 Q2	$10.6M	Buy	21,854 +14,742	+207%	+$7.4M	0.02%	716
2024 Q1	$3.84M	Buy	+7,112	New	+$3.89M	0.01%	1498
2023 Q2	–	Sell	-478	Closed	-$229K	–	4555
2023 Q1	$239K	Sell	478 -4,091	-90%	-$1.96M	﹤0.01%	2326
2022 Q4	$1.86M	Buy	+4,569	New	+$1.77M	0.03%	626
2021 Q4	–	Sell	-914	Closed	-$568	–	2194
2021 Q3	$568	Buy	+914	New	+$614K	0.02%	732

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Capital's IDXX Position: Q1 2026 in Review

Walleye Capital reduced its Idexx Laboratories (IDXX) stake by 99% in Q1 2026, selling an estimated $8.5M and leaving 170 shares worth $95.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3692.

Walleye Capital first reported a position in IDXX in Q3 2021 and has held it in 12 quarters since. The position peaked at $15.6M in Q3 2024. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Walleye Capital held 170 shares of Idexx Laboratories worth $95.5K as of Q1 2026.
Walleye Capital sold 13,261 Idexx Laboratories shares in Q1 2026, an estimated $8.5M.
Idexx Laboratories made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3692 holding.
Walleye Capital first reported a position in Idexx Laboratories in Q3 2021 and has held it in 12 quarters since.
Walleye Capital's Idexx Laboratories position peaked at $15.6M in Q3 2024.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.